Experience Exactech. A Great Day in the O.R.
Corporate Home Page
Exactech, Inc. is an orthopaedic company that develops, manufactures, markets, distributes and sells orthopaedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally.
Recent News
- Exactech Q3 Revenue $42.4M; Net Income $2.7M or $0.21 EPS
- GAINESVILLE, Fla. – October 27, 2009 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that total revenue for the third quarter of 2009 increased 12% to $42.4 million from $37.9 million in the third quarter of 2008. Diluted earnings per share for the quarter was $0.21 based on net income of $2.7 million. This compares with net income of $2.1 million or $0.16 diluted EPS a year ago. Net income for the quarter, excluding pre-tax legal expenses and costs of $845,000 related to the ongoing Department of Justice (DOJ) inquiry, was $3.3 million or $0.25 EPS.
- Exactech Named As One Of America's 200 Best Small Companies by Forbes.com
- Exactech, Inc. (Nasdaq: EXAC), has been Ranked #188 on the list of America's 200 Best Small Companies published by Forbes.com.
